Leap of Faith: Branding and ROI

Not only did Shakespeare know a great deal about human nature, he knew something about brand equity: a name has value. Four hundred years later, marketers grapple to understand the association between brands and profitability.

Articles in this issue

over 24 years ago

Article

Never Say “No Comment”

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Leap of Faith: Branding and ROI

Articles in this issue

Related Content

EMA’s CHMP Recommends Eli Lilly’s Jaypirca for Approval

The New Healthy Aging Imperative and What It Means for Pharma

Reading Between the Lines: Closing the T1D Misdiagnosis Gap

Pharmaceutical Executive Daily: FDA Clears Trodelvy for First-Line Metastatic Triple-Negative Breast Cancer

Beyond the Strip: Las Vegas Has a New Kind of Venture in Mind

Trending on PharmExec

EMA’s CHMP Recommends Eli Lilly’s Jaypirca for Approval

Reading Between the Lines: Closing the T1D Misdiagnosis Gap

Pharmaceutical Executive Daily: FDA Clears Trodelvy for First-Line Metastatic Triple-Negative Breast Cancer

Novartis Announces $105 Million Collaborative Agreement with Antares Therapeutics

The Rise of Direct-to-Patient Models in Pharma: Opportunities and Risks in Bypassing Traditional Distribution Channels